Enzyvant Announces Merger with Altavant
December 06, 2022 08:00 ET
|
Enzyvant Therapeutics
CARY, N.C., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Enzyvant Therapeutics, Inc. and Altavant Sciences, Inc., both wholly owned subsidiaries of Sumitovant Biopharma Ltd., today announced a merger to form a...